NCT03722355 2019-11-12
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
Radiation Therapy Oncology Group
Phase 3 Completed
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Isarna Therapeutics GmbH
INSYS Therapeutics Inc